Company claims signs of success with CRISPR-edited stem cell transplants for two genetic diseases Posted by Paul Battista in biotech/medical, genetics Dec 32019 Editing of hemoglobin gene leads two people with different conditions to no longer need regular blood transfusions. Read more | >
